July 17, 2026 11:44 pm (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Reliance Industries posts record quarterly revenue of ₹3.4 lakh crore, Jio IPO on the horizon
Fri, Jul 17 2026
TCS, Google Cloud launch Gemini Experience Center in Kolkata
Fri, Jul 17 2026
Uber makes massive $14.8 billion bet to take over Delivery Hero
Fri, Jul 17 2026
CEAT shares crash over 9% after tyre maker's Q1 profit plunges 96%
Fri, Jul 17 2026
